Company history

PolyTherics was formed in 2002 with technology that originated at the London School of Pharmacy and Imperial College London. One of the three founding scientists, Dr Steve Brocchini is the Company’s Chief Scientific Officer. The initial seed funding was provided by the Bloomsbury Bioseed Fund and The Wellcome Trust’s Catalyst Biomedica.

In June 2007 the Company received a further investment of £2.3m from Imperial Innovations Group plc, Longbow Capital and the Regional Venture Capital Fund for London. In February 2010 Imperial Innovations Group plc, Longbow Capital and the Capital Fund made a follow-on investment of £3m.